MPS Pharmaa Ltd
MPS Pharmaa Ltd Live Price Chart
Performance
| Previous Close | ₹ |
| High | ₹ |
| Volume | |
| 52W Range | ₹ - ₹ |
| Open | ₹ |
| Low | ₹ |
| Market Cap | ₹ 3.63 Cr |
MPS Pharmaa Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
MPS Pharmaa Ltd Fundamentals
| ROCE | -13.923 |
| P/E Ratio | -3.690 |
| P/B Ratio | 53.270 |
| Industry P/E | 53.270 |
| Debt to Equity | 51.431 |
| ROE | -1,489.051 |
| EPS | -0.540 |
| Dividend Yield | 0.000 |
| Book Value | 0.037 |
| Face Value | 10.000 |
MPS Pharmaa Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 0.0477204 | 0.0936669 | 0.0233 | 0.2905713 | 0.1952035 |
| Total Expenses | 0.9115737 | 0.9469803 | 1.0942422 | 1.2230441 | 4.6893028 |
| Profit After Tax | -0.8978995 | -0.8310417 | -1.0503882 | -0.1415806 | -4.4165108 |
MPS Pharmaa Ltd Shareholding Pattern
| Promoter Holdings | 35.892 % |
| FIIs | 0.000 % |
| DIIs | 0.577 % |
| MutualFund | 0.000 % |
| Retail | 37.941 % |
| Others - | 25.590 % |
About MPS Pharmaa Ltd
MPS Pharmaa Limited, formerly known Advik Laboratories Limited was incorporated in September, 1994. The name of the Company was changed from Advik Laboratories Limited to MPS Pharmaa Limited on December 13, 2022. The Company was promoted in by the Jains along with a group of dedicated professionals. Presently, it is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. The Company commenced commercial production in 1997. In his leadership, the Company witnessed a fast growth rate, without compromise to quality. During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level. In 2021-22, the Company became an Associate Company of Vikas Lifeca ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 43.53 -0.38 (-0.87%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 515.05 -1.35 (-0.26%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,081.00 -40.1 (-0.56%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 587.05 +27.95 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,740.00 +361.6 (+1.37%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,418.00 -1.9 (-0.13%) |
FAQs on MPS Pharmaa Ltd
1. Can I buy MPS Pharmaa Ltd from PL Capital? ›
2. Does MPS Pharmaa Ltd pay dividends? ›
3. What is the current share price of MPS Pharmaa Ltd ? ›
4. What is the 52-week high and low of MPS Pharmaa Ltd ? ›
Start SIP in MPS Pharmaa Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
